Drugs / Chlorohexidine Gluconate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03887299 | Apr 2019 → Jan 2020 | skin infection | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT04155697 Comparator | Jun 2017 → Sep 2018 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT02662374 Background | Sep 2015 → Apr 2016 | chemotherapy-induced oral mucositis | Riyadh Colleges of Dentistry and Pharmacy | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chlorohexidine Gluconate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02662374 ↗ |
| Known as | CHG | “ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG)” NCT03887299 ↗ |
| Route | Other | “5ml of the drug in mouthwash form to be swished four times a day” NCT02662374 ↗ |